In addition, it was found that OCT4 can be upregulated by stimulating STAT3/DNA methyltransferases (DNMTs), and inhibiting DNMTs can increase sensitivity to sorafenib in HCC cell lines and in animal models [139]. The gene discussed is POU5F1; the disease is hepatocellular carcinoma.